What Anova Enterprises does

Anova Enterprises is a privately held, technology-enabled contract research organization (CRO) founded in 2017 and headquartered in Schaumburg, Illinois, with an additional UK office in London. The company operates the AnovaOS™ platform, an integrated clinical research network that connects 15,000+ sponsors, 130,000+ active studies, 15,000+ investigational products, 40,000+ research sites, and 100,000+ investigators, with the stated goal of accelerating clinical development for oncology, neurology, urology, infectious disease, immunology, cardiology, and rare disease therapeutics.

The AnovaOS platform comprises interconnected modules covering protocol structuring and eligibility codification, site and physician qualification, patient matching, site activation (advertised as 5 working days via master contract and fee schedule), data capture, and essential document management. In 2025, the company launched a free AI-enabled patient matching solution covering 200,000+ open trials and a 21 CFR Part 11 compliant Global Clinical Registry, and scaled a Virtual Urology Research Network to 500+ active sites. The platform is HIPAA and 21 CFR Part 11 compliant, supporting both interventional trials and compassionate use programs.

Anova's business model combines enterprise services and platform subscriptions targeted at biopharmaceutical sponsors and CROs, complemented by a self-serve, free AI patient-matching funnel for patients and individual research sites. Pricing is quote-based and not publicly disclosed. The company generates revenue through technology-enabled CRO engagements, including ongoing programs with Denovo Biopharma (DB107 gene therapy in high-grade glioma, supported by an $11.8M CIRM grant), NeOnc Technologies (NEO212, NEO100), and Dizal Pharmaceuticals (DZD9008 for EGFR Exon20ins NSCLC). Leadership includes co-founders Chris Beardmore (CEO) and Martin Walsh (President), with senior executives added in 2025 including CMO Dr. Fred Ma, VP Clinical Development Adam Callahan, and CFO Rhonda Rosen.

Name

Anova Enterprises

Legal name

Anova Enterprises, Inc.

Website

https://anovaevidence.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Short description

Anova Enterprises is a technology-enabled CRO operating the AnovaOS™ platform, which connects biopharma sponsors, research sites, and patients to accelerate clinical trial design, site activation, patient matching, and enrollment across oncology, neurology, urology, and rare diseases.

Ownership category

akta.pro rank

Product category

Clinical Trial Technology

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Custom Computer Programming Services (541511)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)

akta.pro primary industry

Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)

akta.pro secondary industries

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Clinical CROs (Phase I–IV) (HLAGAAAA)

Keywords

• Clinical trial technology
• Patient matching platform
• Contract research services
• Clinical site activation
• Real-world evidence registry

Headquarters

HQ city

Chicago

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Distribution channels3 records

Marketing channels4 records

Core offering

Anova Enterprises operates AnovaOS™, a proprietary technology-enabled CRO platform that connects biopharmaceutical sponsors, research sites, physicians, and patients to accelerate clinical development. The platform delivers AI-enabled patient matching, digital feasibility assessments, automated site activation, remote monitoring, document/data management, and a global clinical registry across an integrated network of 40,000+ research sites and 100,000+ investigators. Anova supplements the platform with full-service CRO engagements and consulting for therapeutic areas including oncology, neurology, immunology, cardiology, infectious disease, and rare disease.

Product overview

Anova Enterprises offers AnovaOS™, a unified clinical research technology platform that integrates an ecosystem of sponsors, research sites, physicians, and patients for accelerated clinical development. The platform comprises multiple interconnected modules including patient matching and enrollment, site activation, data capture and evidence generation, essential document management, and a global clinical registry. Additional offerings include a free AI-enabled patient matching solution using proprietary algorithms, a Network Powered Patient Registry study (NCT05013944) for real-world evidence, and a Virtual Urology Research Network sub-network with 500+ sites. The platform supports both clinical trials and compassionate use programs, enabling just-in-time access to any investigational product.

Differentiator

Problem solved

Functional benefit

Brands

• AnovaOS: Proprietary clinical research technology platform providing an integrated research network of sponsors, studies, investigational products, research sites, and investigators. Enables patient matching, site activation, and clinical trial management.

Products and services

• AnovaOS™ Platform Clinical research technology platform providing an integrated research network that connects sponsors, research sites, physicians, and patients. Enables study feasibility, patient matching, site activation, patient enrollment, data capture, and compassionate use program management for biopharmaceutical sponsors and research sites.
• AnovaOS® Global Clinical Registry 21 CFR Part 11 compliant global clinical registry providing real-world evidence about research sites and patients, administrative efficiency in research conduct, post-market surveillance, and data-driven study design support for sponsors and research sites.
• AI-Enabled Patient Matching Solution Free AI-powered patient matching solution using proprietary algorithms to connect patients to over 200,000+ open clinical trials with high-confidence eligibility matching. Automates screening and integrates into study coordination workflows for patients and participating research sites.
• Network Powered Patient Registry Global patient registry study (NCT05013944) capturing clinically meaningful real-world data on patient diagnosis, nature, course of infection, treatment(s), and outcomes for patients with complex and rare diseases, available to sponsors and research sites through the AnovaOS network.
• Virtual Urology Research Network Virtual urology research network of 500+ quality-confirmed research sites enabling rapid site-to-study matching, streamlined study start-up, and faster patient enrollment for urology clinical research programs.
• Clinical Development & Technical Consulting Services Consultancy services to accelerate clinical development and technical services for data integration, advanced analytics, and clinical evidence generation for biopharmaceutical sponsors and research partners.

Quantifiable outcome

• Free AI-enabled patient matching solution available to patients

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Recent moves8 records

Expansion highlights7 records

Emerging players

• Antidote Technologies: Digital patient recruitment and clinical trial matching company connecting patients to trials through machine learning. Closely comparable to Anova's free AI patient matching solution and the broader site/patient matching value proposition, with overlap in biopharma and patient-direct channels.
• Medable: Technology-focused clinical trial platform offering eCOA, telehealth, and decentralized trial capabilities, including patient matching and site enablement. Comparable to Anova as a tech-enabled trial enablement vendor overlapping on patient recruitment and remote monitoring, though Medable focuses on DCT workflows rather than full-service CRO.
• Science 37: Decentralized clinical trial operating company combining technology and telemedicine for site-less and remote trials. Comparable to Anova on patient recruitment, remote monitoring, and tech-enabled trial enablement, with overlap in biopharma oncology and rare-disease sponsors.
• Castor EDC: Cloud-based clinical data capture platform with eCRF, EDC, ePRO, and decentralized trial features used by sponsors and CROs. Comparable to Anova on clinical data management and trial enablement tooling, though positioned as a data-capture software vendor rather than full-service CRO.
• Trial Library: AI-driven patient recruitment and trial feasibility platform for sponsors and CROs. Directly comparable to Anova's AI patient matching and digital feasibility modules, focused narrowly on recruitment and protocol feasibility.

Broad incumbents

• IQVIA: Global full-service CRO and life-sciences technology vendor with extensive clinical trial management, patient recruitment, and real-world evidence capabilities. Comparable to Anova as a sponsor-facing CRO with technology-enabled services, but at vastly larger scale and broader portfolio.
• Syneos Health: Large global CRO offering clinical development and commercial services across all phases. Comparable to Anova as a clinical CRO serving biopharma sponsors, including patient recruitment and site activation workflows, though with a much larger employee base and global delivery footprint.
• ICON plc: Top-tier global CRO providing outsourced drug development and clinical trial services. Comparable to Anova as a clinical CRO targeting biopharma sponsors across therapeutic areas, though serving at significantly larger enterprise scale.
• Veeva Systems: Life-sciences cloud vendor offering CTMS, EDC, eTMF, and clinical data management software. Comparable to Anova on the clinical trial informatics layer (CTMS/EDC/eTMF overlap with AnovaOS modules) and target sponsor customer base, but as a software vendor rather than a CRO.
• Medidata (Dassault Systèmes): Industry-standard clinical trial technology platform (Rave EDC, CTMS, eCOA, RTSM) serving biopharma sponsors and CROs. Comparable to Anova on clinical trial informatics, data capture, and trial enablement, with substantial overlap in biopharma customers.

Market position

Strengths6 records

Weaknesses4 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/AnovaEvidence

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Anova Enterprises